Archive WILEX Ad-hoc- and Press Releases 2005


Selected press releases of the former years can be found here.

19 September 2005
WILEX appoints Norman Neville as Vice President Clinical Research & Development
27 July 2005
WILEX successfully completes first clinical Phase I study with new anti-cancer drug
21 June 2005
FierceBiotech honors WILEX AG as one of the “Fierce 15” Biotech Companies of 2005
19 May 2005
WILEX’s anti-cancer drug RENCAREX®* significantly prolongs survival in metastatic
Renal Cell Cancer
10 May 2005
WILEX closes a EUR 30 million ($ 39 million) series C private equity round

* temporary name while under development

Seite gelesen: 470 | Heute: 3